Navigation Links
Isis Pharmaceuticals And AstraZeneca Form Strategic Alliance On RNA Therapeutics For Cancer
Date:12/11/2012

r all development of ISIS-STAT3Rx other than the conduct of the ongoing clinical trial, which Isis will complete. Isis is eligible to receive further milestone payments subject to achieving certain predefined clinical success criteria for the ISIS-STAT3Rx program and pre-clinical milestones for the other programs. Isis is also eligible to receive downstream development and approval milestone payments, license fees for research program targets as well as royalties on sales from products that are successfully commercialized.

Isis will hold a conference call and live audio webcast today, December 11, 2012 at 8:30 am ET to provide detailed information on its new strategic alliance with AstraZeneca. Interested parties may listen to the call by dialing 866-713-8567and refer to passcode "ISIS 2012," or access the webcast at www.isispharm.com

ABOUT ISIS-STAT3Rx
ISIS-STAT3Rx is the first drug in Isis' pipeline that incorporates Isis' Generation 2.5 chemistry, which was developed to increase potency of antisense drugs thereby creating opportunities for drugs like ISIS-STAT3Rx to be more effective in addressing targets in a broader range of tissues, including tumors. ISIS-STAT3Rx is designed to inhibit the production of signal transducer and activator of transcription 3 (STAT3), a protein critical for tumor growth and survival. Because STAT3 is overexpressed in numerous types of cancers, ISIS-STAT3Rx has the potential to be broadly useful for both solid and hematological tumors. Isis recently reported encouraging data from its ongoing Phase 1 study showing that ISIS-STAT3Rx had an acceptable safety profile and treatment with ISIS-STAT3Rx resulted in clear responses in a number of patients with advanced cancer who were refractory to multiple prior chemotherapy treatments. The indication of activity so early in devel
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders
2. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
3. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
5. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
6. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
7. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
8. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
9. Salix Pharmaceuticals Donates $500,000 To ASGEs IT&T Capital Campaign To Build A New State-of-the-Art GI Training Center
10. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
11. Double-digit Growth Rate of the Pharmaceuticals Industry in Asia Pacific Boosts the API Market, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Reportlinker.com announces that a ... its catalogue: Needle-Free Delivery: Technology ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html Report Details ... commercial prospects What does the future hold ... new report shows you the potential revenues ...
(Date:8/28/2014)... , Aug. 28, 2014  Decision Resources Group ... will grow strongly through 2022 at a compound ... will be largely supported by strong population growth ... demand for imaging procedures. The Indian government,s greater ... facilities to purchase or upgrade diagnostic imaging equipment. ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- EDGE Orthopaedics, ... space, is excited to announce they have received ... Plating System and REDUCE Fracture Plating System. ... used to support multiple indications within the mid-foot. ... First Metatarsophalangeal (MTP), Calcaneal-Cuboid (CC), Talonavicular (TN) and ...
Breaking Medicine Technology:Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 2Indian Diagnostic Imaging System Market Will Grow at 6 Percent Annually Through 2022 3EDGE Orthopaedics Receives Second FDA Clearance 2
... NEW YORK, Aug. 25 Reportlinker.com ... report is available in its catalogue: ... the Asia-Pacific Region – India and ... still dominates high value transactions ...
... (Nasdaq: BIOD ) today announced that it has ... 2,398,200 shares of its common stock and warrants to purchase ... warrants are being sold as units, with each unit consisting ... purchase one share of common stock.   The ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 2Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 3Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 4Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 5Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 6Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 7Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 8Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions 9Biodel to Raise $9.4 Million Through Registered Direct Offering 2Biodel to Raise $9.4 Million Through Registered Direct Offering 3
(Date:8/29/2014)... (PRWEB) August 29, 2014 As a ... City, Fla., understands that there’s a direct connection between ... knees, hips and back. "Since conventional shoe inserts and ... a solution of my own," he said. , Customizable ... provides better support for the foot in order to ...
(Date:8/29/2014)... 29, 2014 Glendale Botox experts ... on Botox throughout the month of September. This special offer ... two syringes of Juvederm. Patients can take advantage of this ... The Glendale Botox experts will work with patients to determine ... What is Botox? , Botox is a treatment ...
(Date:8/29/2014)... (HealthDay News) -- The main strain of a ... and North Africa originated in sub-Saharan Africa, a ... methicillin-resistant Staphylococcus aureus (CA-MRSA) infections, which ... been hospitalized. These infections typically affect the skin ... through touching contaminated objects such as clothing or ...
(Date:8/29/2014)... 2014 (HealthDay News) -- The way that parents respond ... development, a new study suggests. Over six months, ... infants during free play. The sessions were 30 minutes ... 8 months old at the start of the study. ... babbling, infants began to form complex sounds. The babies ...
(Date:8/29/2014)... August 29, 2014 For the fifth ... (Meso Foundation) will be observing September 26th as Mesothelioma ... Plaza, in New York. , Members of the ... RSVP . The Foundation will be providing t-shirts and ... years, mesothelioma community members have received attention from ...
Breaking Medicine News(10 mins):Health News:Glenoaks Laser Center is Now Offering a Special Promotion on Botox for the Month of September 2Health News: European MRSA Originated in Sub-Saharan Africa, Study Finds 2Health News:Encouraging Your Baby's Babbling May Speed Language Development 2Health News:Organization to Raise Awareness of Mesothelioma on the Today Show 2
... mental function, study says , , THURSDAY, June 12 ... to fight cancer may reduce disease activity and disability ... small trial suggest. , In relapsing-remitting MS, the ... of symptoms followed by stretches of symptom-free remission when ...
... 12 Cancer Clinics of Excellence (CCE), the,nation,s ... has announced its management slate and Board of ... CCE. Most,recently, he was the interim President of ... Group was named Chief Medical,Officer. Dr. Bosserman had ...
... 12 Do you know a,Champion?, The ... working to improve Oklahoma,s health. The 2008 Champions ... are making a,significant difference in the health of ... Friday, Aug. 1., Nominations can be submitted ...
... June 12 The Arizona Board of Regents,recently ... of Arizona,College of Medicine Program in Integrative Medicine ... medicine has had on health-care,system transformation., Now ... (AzCIM), the,program underwent an intensive evaluation process and ...
... performance and lifestyle brand is paired with LensCrafters, ... 500 North American stores, MASON, Ohio, June ... at more than 500 select LensCrafters locations, North ... customers the,combined benefits of Oakley,s popular and innovative ...
... to call, write letters to Schwarzenegger,expressing their outrage, ... of home healthcare workers will rally to protest ... service, wages and,benefits. These dramatic reductions would force ... they serve deeper into poverty. It also,will force ...
Cached Medicine News:Health News:Cancer Drug Appears to Help With Aggressive MS 2Health News:Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting 2Health News:Nominations Accepted for 2008 'Champions of Health' Awards 2Health News:The University of Arizona Program in Integrative Medicine Earns 'Center of Excellence' Designation 2Health News:The University of Arizona Program in Integrative Medicine Earns 'Center of Excellence' Designation 3Health News:Oakley Prescription Eyewear Now at Lenscrafters 2Health News:Oakley Prescription Eyewear Now at Lenscrafters 3Health News:Oakley Prescription Eyewear Now at Lenscrafters 4
... eye-nasal. High volume/low pressure cuff. X-ray ... surgical access. Designed to reduce kinking ... preformed curvature. Thin-walled, large volume low-pressure ... the anatomical situation at body temperature. ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
... For Laryngotracheal Instillation of Topical Anesthetic, ... populations, this cuffed tube incorporates an ... spray application of topical anesthetic above ... offers three endotracheal tubes designs which ...
Medicine Products: